| Members |
targetComponentId |
| Genus Ictalurid herpes-like viruses |
Genus Ictalurivirus (organism) |
| Genus Infectious laryngo-tracheitis-like viruses |
Genus Iltovirus (organism) |
| Genus Marburg-like viruses |
Genus Marburgvirus (organism) |
| Genus Marek's disease-like viruses |
Genus Mardivirus (organism) |
| Genus Melanonycteris |
Genus Melonycteris |
| Genus Mungoticitis |
Genus Mungotictis |
| Genus Nesochen |
Branta |
| Genus Notornis |
Genus Porphyrio (organism) |
| Genus Oncifelis |
Genus Leopardus (organism) |
| Genus Otocolobus |
Genus Felis (organism) |
| Genus Parahyaena |
Genus Hyaena (organism) |
| Genus Pelomonas |
Genus Roseateles (organism) |
| Genus Pennisetum |
Genus Cenchrus (organism) |
| Genus Picornavirus |
Family Picornaviridae (organism) |
| Genus Pseudobacillus |
Order Bacillales (organism) |
| Genus Quadricoccus |
Genus Quatrionicoccus (organism) |
| Genus Salinococcus |
Genus Salinicoccus |
| Genus Serpens |
Pseudomonas |
| Genus Sulfolobococcus |
Genus Sulfophobococcus (organism) |
| Genus Teichococcus |
Roseomonas |
| Genus Weizmannia |
Genus Heyndrickxia (organism) |
| Geochelone elephantopus |
Geochelone nigra (organism) |
| Geochelone elongata |
Indotestudo elongata (organism) |
| Gerbich type |
Gerbich type |
| Geriatric screening refused |
Geriatric screening declined (situation) |
| Geriatric screening refused |
Geriatric screening declined (situation) |
| Gerlier's disease |
Epidemic vertigo |
| Gestational diabetes mellitus, class B |
Gestational diabetes mellitus |
| Gestational diabetes mellitus, class B>1< |
Gestational diabetes mellitus |
| Gestational diabetes mellitus, class C |
Gestational diabetes mellitus |
| Gestational diabetes mellitus, class D |
Gestational diabetes mellitus |
| Gestational diabetes mellitus, class F |
Gestational diabetes mellitus |
| Gestational diabetes mellitus, class H |
Gestational diabetes mellitus |
| Gestational diabetes mellitus, class R |
Gestational diabetes mellitus |
| Gestational diabetes mellitus, class T |
Gestational diabetes mellitus |
| Gestational trophoblast TNM finding |
American Joint Committee on Cancer allowable value |
| Gianotti-Crosti syndrome |
Gianotti-Crosti syndrome |
| Giant |
Gigantism |
| Giant cell hepatitis causing neonatal jaundice |
Early neonatal jaundice due to hepatitis |
| Giant condyloma acuminatum |
Verrucous carcinoma |
| Gianturco-Roehm filter |
Vena cava filter |
| Giesbergeria sinuosum |
Giesbergeria sinuosa |
| Gingival flap |
Flap (substance) |
| Gingival lamina dura structure |
Structure of lamina dura of tooth socket |
| Girlfriend of subject |
Girlfriend |
| Glabellar flap |
Flap (substance) |
| Gland contrast radiography NOS |
Plain X-ray of gland with contrast (procedure) |
| Gland contrast radiography NOS |
Plain X-ray of gland with contrast (procedure) |
| Glandular intraepithelial neoplasia, grade III |
High grade glandular intraepithelial neoplasia |
| Glass fragment, device |
Glass fragment (physical object) |
| Glaucoma associated with disorders of the lens NOS |
Phacogenic glaucoma |
| Glaucoma associated with ocular inflammation |
Glaucoma due to eye inflammation (disorder) |
| Glaucoma caused by silicon oil |
Glaucoma caused by silicone oil |
| Glaucoma following surgery |
Open angle glaucoma due to ocular surgery (disorder) |
| Glaucoma suspect |
Glaucoma suspect |
| Gliding bacteria |
Non-photosynthetic, non-fruiting gliding bacteria |
| Glioblastoma - category |
Glioblastoma |
| Glioblastoma, no International Classification of Diseases for Oncology subtype |
Glioblastoma |
| Glipizide 10mg m/r tablet |
Product containing only glipizide in oral dose form (medicinal product form) |
| Glipizide 10mg prolonged-release oral tablet |
Product containing only glipizide in oral dose form (medicinal product form) |
| Glipizide 2.5mg m/r tablet |
Product containing only glipizide in oral dose form (medicinal product form) |
| Glipizide 2.5mg prolonged-release oral tablet |
Product containing only glipizide in oral dose form (medicinal product form) |
| Glipizide 5mg m/r tablet |
Product containing only glipizide in oral dose form (medicinal product form) |
| Glipizide 5mg prolonged-release oral tablet |
Product containing only glipizide in oral dose form (medicinal product form) |
| Globus abdominalis |
Functional bloating (disorder) |
| Glomus jugulare tumor |
Malignant glomus jugulare tumor |
| Glomus neoplasm of mastoid |
Benign glomus tumor of mastoid |
| Glomus tumor |
Benign glomus tumour |
| Glomus tumor |
Benign glomus tumour |
| Glomus tumor of ear |
Benign glomus tumor of ear (disorder) |
| Glomus tumor of skin |
Benign glomus tumor of skin |
| Glomus tumour |
Benign glomus tumour |
| Glomus vagale tumor |
Malignant vagal paraganglioma (disorder) |
| Glottis TNM finding |
American Joint Committee on Cancer allowable value |
| Glucagonoma |
Malignant glucagonoma of pancreas (disorder) |
| Glucagonoma |
Glucagonoma, malignant |
| Glucagonoma of uncertain behavior |
Malignant glucagonoma of pancreas (disorder) |
| Glucagonoma of uncertain behavior |
Glucagonoma, malignant |
| Gluconobacter oxydans subspecies industrius |
Gluconobacter oxydans (organism) |
| Gluconobacter oxydans subspecies melanogenes |
Gluconobacter oxydans (organism) |
| Gluconobacter oxydans subspecies oxydans |
Gluconobacter oxydans (organism) |
| Gluconobacter oxydans subspecies sphaericus |
Gluconobacter oxydans (organism) |
| Gluconobacter oxydans subspecies suboxydans |
Gluconobacter oxydans (organism) |
| Glucose 10% infusion solution bottle |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Glucose 15% infusion solution bottle |
Product containing precisely glucose 150 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Glucose 20% infusion solution 500 mL polyethylene bottle |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Glucose 20% infusion solution bottle |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Glucose 40% infusion solution bottle |
Glucose 400 mg/mL solution for injection |
| Glucose 50% infusion solution bottle |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Glucose 50% injection solution prefilled syringe |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Glucose 70% infusion solution bag |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Glucose in sample |
Glucose level - finding |
| Gluma - Dentine bonding agent |
Dentine bonding agent (substance) |
| Gluphosphate causing toxic effect |
Glyphosate toxicity |
| Glycerin 10% conventional release eye drops |
Glycerol 10 mg/mL eye solution |
| Glycerin 10% preservative-free eye drops |
Glycerol 10 mg/mL eye solution |
| Glycerin 20% conventional release eye drops |
Product containing only glycerol in ocular dose form (medicinal product form) |
| Glycerin 20% preservative-free eye drops |
Product containing only glycerol in ocular dose form (medicinal product form) |
| Glycerin 30% conventional release eye drops |
Product containing only glycerol in ocular dose form (medicinal product form) |
| Glycerin 30% preservative-free eye drops |
Product containing only glycerol in ocular dose form (medicinal product form) |
| Glycerin 50% conventional release eye drops |
Glycerol 500 mg/mL eye solution |
FHIR